
Pasithea (KTTA) Stock Spikes On Its Latest Clinical Trial Milestone
Pasithea Therapeutics Corp. (NASDAQ: KTTA) had a notable increase in its share price today, rising 34.13% to $2.79 as of the most recent check. This
Home » NASD:KTTA
Pasithea Therapeutics Corp. (NASDAQ: KTTA) had a notable increase in its share price today, rising 34.13% to $2.79 as of the most recent check. This
Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares are gaining significantly traction in the pre-market session today, following the release of promising interim data from its ongoing
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.